Skip to main content

Table 3 Renal mass complexity according to R.E.N.A.L. NS in relation to outcome parameters

From: Modified R.E.N.A.L nephrometry score for predicting the outcome following partial nephrectomy

 

Complexity level according to R.E.N.A.L.

p

Low (4–6)

11 patients

Moderate (7–9)

20 patients

High (10–12)

20 patients

Age (years)

48.1 ± 13.1 (20–59)

50.3 ± 10.1 (34–65)

51.1 ± 16.2 (20–80)

.861

BMI (kg/m2)

32 ± 6.7 (22–42)

28.5 ± 4.3 (22–36)

29.6 ± 4.9 (21–39)

.117

ASA Score

1 (1–2)

1 (1–2)

2 (1–2)

.441

Pre-Op eGFR (ml/min/1.73m2)

86.1 ± 20.9 (55–141)

76.9 ± 18.6 (43–126)

91 ± 30 (40–140)

.183

Pre-Op Hb (gm/dl)

14.1 ± 1.05 (13–15.9)

13.2 ± 1.8 (10.5–16.4)

12.6 ± 1.7 (9.1–15.5)

.064

Sex: male/female

7 (63.6%)/4 (36.4%)

13 (65%)/7 (35%)

9/(45%)/11 (55%)

.388

Side: right/left

8 (72.7%)/3 (27.3%)

12 (60%)/8 (40%)

10 (50%)/10 (50%)

.465

CKD (ml/min/1.73m2)

   

.104

 > 90

4/11 (36.4%)

3/20 (15%)

10/20 (50%)

 60–89

6/11 (54.5%)

14/20 (70%)

6/20 (30%)

 30–59

1/11 (9.1%)

3/20 (15%)

4/20 (20%)

Clinical T

   

.095

 T1

10/11 (90.9%)

15/20 (75%)

11/20 (55%)

 T2

1/11 (9.1%)

5/20 (25%)

9/20 (45%)

OR time (h)

2.6 ± 0.57 (1.7–3.5)

3.1 ± 0.78 (2–5)

3.03 ± 0.65 (2–4.5)

.174

WIT (min)

14 (0–20)

15 (0–30)

19 (0–40)

.343

LOS (days)

4 (3–9)

5 (4–29)

5 (4–11)

.109

Hb loss (gm/dl)

1 (0.4–3.5)

1 (0.2–3.7)

1 (0.1–5.3)

.788

Blood loss (ml)

150 (50–1500)

300 (100–900)

300 (50–1100)

.272

Ischemia type

   

.251

 Warm ischemia

7/11 (63.6%)

18/20 (90%)

15/20 (75%)

 No ischemia

4/11 (36.4%)

2/20 (10%)

5/20 (25%)

Hilar position

0/11

3/20 (5.9%)

7/20 (13.7%)

.053

RPS

    

 Intrarenal/extrarenal

7 (63.6%)/4 (36.4%)

14 (70%)/6 (30%)

14 (70%)/6 (30%)

.922

PCS entry

5/11 (45.5%)

8/20 (40%)

13/20 (65%)

.263

Post-Op Hb (gm/dl)

12.6 ± 1.5 (10 - 14.3)

11.9 ± 1.6 (9 - 15.8)

11.3 ± 2 (7.1–15)

.148

Total complications

2/11 (18.2%)

9/20 (52.9%)

6/20 (30%)

.292

Secondary intervention

2/11 (18.2%)

7/20 (35%)

1/20 (5%)

.039*

VC

1/11 (9.1%)

2/20 (10%)

1/20 (5%)

1

Ureteric injury

0/11

2/20 (10%)

0/20

.341

Blood transfusion

2/11 (18.2%)

3/20 (15%)

4/20 (20%)

1

Leakage

0/11

5/20 (25%)

1/20 (5%)

.124

Drain removal (d)

4 (3–8)

4.5 (3–28)

5 (4–7)

.243

Conversion to RN

1/11 (9.1%)

1/20 (5%)

2/20 (10%)

1

RF impairment

1/11 (9.1%)

2/20 (10%)

3/20 (11.8%)

1

Positive margin

0/11

1/20 (5%)

2/20 (10%)

.789

Post-Op eGFR 3mo (ml/min/1.73m2)

78.6 ± 17.5 (60–114.3)

74.8 ± 19.3 (32–117)

80.1 ± 27 (21.8–130)

.750

  1. Values are presented as mean ± SD (range), Median (range) or number of patients (%) as appropriate
  2. AML angiomyolipoma, ASA American society of anesthesiology, BMI body mass index, CKD chronic kidney disease, eGFR estimated glomerular filtration rate, Hb hemoglobin, LOS length of hospital stay, OR operative, PCS pelvi-calyceal system, Post-Op postoperative, Pre-Op preoperative, RF renal function, RN radical nephrectomy, RPS renal pelvic score, VC vascular complications, WIT warm ischemia time
  3. *Significant